Immunotherapy Drug Avelumab Boosts Survival With Bladder Cancer
MONDAY, Sept. 21, 2020 -- An immunotherapy drug significantly improved survival in patients with the most common type of bladder cancer, according to a new study.
About 550,000 new cases of bladder cancer are diagnosed worldwide each year, making...
Source: Drugs.com - Daily MedNews - Category: General Medicine Source Type: news